ADPT Adaptive Biotechnologies Corporation

NASDAQ
$29.43

Adaptive Biotechnologies Corporation (ADPT) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.10 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +32.6% since its last earnings release on July 29, 2026.

Adaptive Biotechnologies Reported In-line with Expectations, Raises Guidance
Wednesday, July 29, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:05 PM ET
Earnings Whisper
-
vs ($0.10)
Rev est $72.18M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $25.49

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Adaptive Biotechnologies Corporation

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.

Sector

Healthcare

Industry

Medical Labs & Research

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.